Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Hendra virus infection is a rare viral infection disorder caused by the Hendra virus characterized by onset of flu-like symptoms (fever, myalgia, headaches, lethargy) approximately one week after having been in close contact with bodily fluids of infected horses. Neurological manifestations (e.g. vertigo, confusion, ataxia) and progressive respiratory failure, leading to death, have also been reported.
Biomarker and diagnostic research for Hendra virus infection has been reported in the published literature.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for Hendra virus infection.
132 publications have been identified in PubMed for Hendra virus infection. Research spans Review / Meta-Analysis (42%), Basic Science / Preclinical (24%), and Epidemiology / Natural History (14%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 49 | 42% |
Data assembled from 3 of 12 sources · Last updated Sep 20, 2026, 1:03 AM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Common questions about Hendra virus infection
28 |
24% |
Disease patterns and progression | 16 | 14% |
Patient case studies | 10 | 9% |
New treatment approaches | 7 | 6% |
Testing and diagnosis research | 5 | 4% |
Clinical study results | 2 | 2% |
Amado C (2026). [PMID: 40975490](https://pubmed.ncbi.nlm.nih.gov/40975490/). *Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology*. [Basic Science / Preclinical]
Pigeaud DD (2026). [PMID: 41484102](https://pubmed.ncbi.nlm.nih.gov/41484102/). *NPJ vaccines*. [Review / Meta-Analysis]
Haidurov A (2026). [PMID: 41972739](https://pubmed.ncbi.nlm.nih.gov/41972739/). *Cells*. [Review / Meta-Analysis]
Kim J (2026). [PMID: 41570456](https://pubmed.ncbi.nlm.nih.gov/41570456/). *Current opinion in virology*. [Basic Science / Preclinical]
Halpin K (2026). [PMID: 41894354](https://pubmed.ncbi.nlm.nih.gov/41894354/). *PLoS Negl Trop Dis*. [Review / Meta-Analysis]
Boyd V (2026). [PMID: 41863545](https://pubmed.ncbi.nlm.nih.gov/41863545/). *Emerg Infect Dis*. [Epidemiology / Natural History]
Lázár E (2026). [PMID: 41028908](https://pubmed.ncbi.nlm.nih.gov/41028908/). *Nature reviews. Genetics*. [Review / Meta-Analysis]
Tee KK (2026). [PMID: 41822329](https://pubmed.ncbi.nlm.nih.gov/41822329/). *Frontiers in cellular and infection microbiology*. [Epidemiology / Natural History]
Jeon S (2025). [PMID: 40404610](https://pubmed.ncbi.nlm.nih.gov/40404610/). *Nat Commun*. [Basic Science / Preclinical]
Navaratnarajah CK (2025). [PMID: 40573457](https://pubmed.ncbi.nlm.nih.gov/40573457/). *Viruses*. [Review / Meta-Analysis]